Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well lenalidomide works in treating older patients with
acute myeloid leukemia with abnormal chromosome 5q. Biological therapies, such as
lenalidomide, may stimulate the immune system in different ways and stop cancer cells from
growing.